<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Identifying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related genes or proteins is critical in preventing and controlling <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This study was to investigate the clinicopathological and prognostic value of activating transcription factor 1 (ATF1) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Protein expression of ATF1 was detected using immunohistochemistry in 66 CRC tissues </plain></SENT>
<SENT sid="3" pm="."><plain>Clinicopathological association of ATF1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was analyzed with chi-square test or Fisher's exact test </plain></SENT>
<SENT sid="4" pm="."><plain>The prognostic value of ATF1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is estimated using the Kaplan-Meier analysis and Cox regression models </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The ATF1 protein expression was significantly lower in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues than corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (51.5% and 71.1%, respectively, P = 0.038) </plain></SENT>
<SENT sid="6" pm="."><plain>No correlation was found between ATF1 expression and the investigated clinicopathological parameters, including gender, age, depth of invasion, lymph node status, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, pathological stage, vascular tumoral emboli, peritumoral deposits, chemotherapy and original <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> site (<z:hpo ids='HP_0000001'>all</z:hpo> with P &gt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with higher ATF1 expression levels have a significantly higher survival rate than that with lower expression (P = 0.026 for overall survival, P = 0.008 for progress free survival) </plain></SENT>
<SENT sid="8" pm="."><plain>Multivariate Cox regression model revealed that ATF1 expression and depth of invasion were the predictors of the overall survival (P = 0.008 and P = 0.028) and progress free survival (P = 0.002 and P = 0.005) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Higher ATF1 expression is a predictor of a favorable outcome for the overall survival and progress free survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>